These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 29790176)

  • 21. Regulatory mechanisms of tau protein fibrillation under the conditions of liquid-liquid phase separation.
    Boyko S; Surewicz K; Surewicz WK
    Proc Natl Acad Sci U S A; 2020 Dec; 117(50):31882-31890. PubMed ID: 33262278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau gene mutations and neurodegeneration.
    Goedert M; Spillantini MG
    Biochem Soc Symp; 2001; (67):59-71. PubMed ID: 11447840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryo-EM structures of tau filaments from Alzheimer's disease.
    Fitzpatrick AWP; Falcon B; He S; Murzin AG; Murshudov G; Garringer HJ; Crowther RA; Ghetti B; Goedert M; Scheres SHW
    Nature; 2017 Jul; 547(7662):185-190. PubMed ID: 28678775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau proteinopathies and the prion concept.
    Goedert M
    Prog Mol Biol Transl Sci; 2020; 175():239-259. PubMed ID: 32958235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes.
    Buchholz S; Zempel H
    Alzheimers Dement; 2024 May; 20(5):3606-3628. PubMed ID: 38556838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
    Spillantini MG; Van Swieten JC; Goedert M
    Neurogenetics; 2000 Mar; 2(4):193-205. PubMed ID: 10983715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau protein pathology in neurodegenerative diseases.
    Spillantini MG; Goedert M
    Trends Neurosci; 1998 Oct; 21(10):428-33. PubMed ID: 9786340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations.
    Xia Y; Sorrentino ZA; Kim JD; Strang KH; Riffe CJ; Giasson BI
    J Biol Chem; 2019 Nov; 294(48):18488-18503. PubMed ID: 31653695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
    Mailliot C; Sergeant N; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L
    FEBS Lett; 1998 Aug; 433(3):201-4. PubMed ID: 9744794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.
    Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM
    J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
    Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
    Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?
    Fichou Y; Al-Hilaly YK; Devred F; Smet-Nocca C; Tsvetkov PO; Verelst J; Winderickx J; Geukens N; Vanmechelen E; Perrotin A; Serpell L; Hanseeuw BJ; Medina M; Buée L; Landrieu I
    Acta Neuropathol Commun; 2019 Mar; 7(1):31. PubMed ID: 30823892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of NFT: Biochemical Approach.
    Hasegawa M
    Adv Exp Med Biol; 2019; 1184():23-34. PubMed ID: 32096025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-8-mediated selective autophagy protects against seeded tau aggregation.
    Falcon B; Noad J; McMahon H; Randow F; Goedert M
    J Biol Chem; 2018 Feb; 293(7):2438-2451. PubMed ID: 29282296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformation determines the seeding potencies of native and recombinant Tau aggregates.
    Falcon B; Cavallini A; Angers R; Glover S; Murray TK; Barnham L; Jackson S; O'Neill MJ; Isaacs AM; Hutton ML; Szekeres PG; Goedert M; Bose S
    J Biol Chem; 2015 Jan; 290(2):1049-65. PubMed ID: 25406315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges.
    Zheng H; Sun H; Cai Q; Tai HC
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules.
    Falcon B; Zivanov J; Zhang W; Murzin AG; Garringer HJ; Vidal R; Crowther RA; Newell KL; Ghetti B; Goedert M; Scheres SHW
    Nature; 2019 Apr; 568(7752):420-423. PubMed ID: 30894745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau pathology: a marker of neurodegenerative disorders.
    Delacourte A; Buée L
    Curr Opin Neurol; 2000 Aug; 13(4):371-6. PubMed ID: 10970052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
    Andorfer C; Kress Y; Espinoza M; de Silva R; Tucker KL; Barde YA; Duff K; Davies P
    J Neurochem; 2003 Aug; 86(3):582-90. PubMed ID: 12859672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.